The expression of protease-activated receptors in esophageal carcinoma cells: the relationship between changes in gene expression and cell proliferation, apoptosis in vitro and growing ability in vivo

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Esophageal Carcinoma

(2014) Anil K. Rustgi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy

(2013) James V. Alvarez et al.   CANCER CELL

Pseudopodial and β-arrestin-interacting proteomes from migrating breast cancer cells upon PAR2 activation

(2013) Nikolaos Parisis et al.   Journal of Proteomics

Oesophageal carcinoma

(2013) Arjun Pennathur et al.   LANCET

Charting a dynamic DNA methylation landscape of the human genome

(2013) Michael J. Ziller et al.   NATURE

TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620

(2013) Lichao Hu et al.   TUMOR BIOLOGY

Selective Inhibitors of Nuclear Export Block Pancreatic Cancer Cell Proliferation and Reduce Tumor Growth in Mice

(2012) Asfar S. Azmi et al.   GASTROENTEROLOGY

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Decreased expression of protease-activated receptor 4 in human gastric cancer

(2011) Yong Zhang et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development

(2010) F. Schaffner et al.   BLOOD

Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer

(2010) Nagai   INTERNATIONAL JOURNAL OF ONCOLOGY

Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis

(2008) Jayashree Joshi et al.   EMBO JOURNAL

Aberrant expression of proteinase-activated receptor 4 promotes colon cancer cell proliferation through a persistent signaling that involves Src and ErbB-2 kinase

(2008) Valérie Gratio et al.   INTERNATIONAL JOURNAL OF CANCER